Other studies found that decreased lymphocyte and platelet counts and elevated levels of CRP, PCT, D-dimer, LDH, liver enzymes, and creatinine were associated with poor outcomes in COVID-19 patients.[8,9,28] However, in an Italian study featuring adjusted analysis, CRP was the only biomarker associated with increased risks of death and ICU admission.[29] We found that decreased lymphocyte and platelet counts; an increased ESR; and increased CRP, PCT, LDH, and ferritin levels were associated with disease severity. The gene discussed is CRP; the disease is COVID-19.